Feng Wang

8PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Chemical engineering designInnate immunityNeurology and neuromuscular diseasesTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 16, 2026
PTMA safeguards mitochondrial integrity to sustain metabolic function and antitumor activity of CD8 T cells.

Keling Huang, Xiaoxue Li, Wenhua Liang

|Oct 16, 2025
TCR signal-enhancing mutation alters lipid metabolism of thymocytes and impairs antitumor immunity of mature T cells.

Wenhua Liang, Yuge Liang, Mingzhu Yu

|Apr 09, 2025
MYO1F in neutrophils is required for the response to immune checkpoint blockade therapy.

Yingying Qu, Wenhua Liang, Mingzhu Yu

|Mar 16, 2023
Bifidobacterium promotes retinal ganglion cell survival by regulating the balance of retinal glial cells.

Xiaohuan Zhao, Mengqiao Xu, Zhenzhen Zhao

|Oct 20, 2022
Enhancing the Antitumor Immunity of T Cells by Engineering the Lipid-Regulatory Site of the TCR/CD3 Complex.

Wenhua Liang, Ruirong Yi, Weifang Wang

|May 31, 2022
Disulfiram bolsters T-cell anti-tumor immunity through direct activation of LCK-mediated TCR signaling.

Qinlan Wang, Ting Zhu, Naijun Miao

Pageof 2

Frequent Collaborators

5 joint publications

Wenhua Liang

2 joint publications

Weifang Wang

1 joint publications

Qibin Leng

1 joint publications

Shan Sun